Cholesterol, Triglycerides, and Associated Lipoproteins
- PMID: 21250192
- Bookshelf ID: NBK351
Cholesterol, Triglycerides, and Associated Lipoproteins
Excerpt
Cholesterol, triglycerides, and high-density lipoproteins are important constituents of the lipid fraction of the human body. Cholesterol is an unsaturated alcohol of the steroid family of compounds; it is essential for the normal function of all animal cells and is a fundamental element of their cell membranes. It is also a precursor of various critical substances such as adrenal and gonadal steroid hormones and bile acids. Triglycerides are fatty acid esters of glycerol and represent the main lipid component of dietary fat and fat depots of animals.
Cholesterol and triglycerides, being nonpolar lipid substances (insoluble in water), need to be transported in the plasma associated with various lipoprotein particles. Plasma lipoproteins are separated by hydrated density; electrophretic mobility; size; and their relative content of cholesterol, triglycerides, and protein into five major classes: chylomicrons, very-low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL).
Since the levels of plasma lipids have a bell-shaped distribution in the general population, the definition of either a high or a low value of these substances has remained an arbitrary statistical decision. High values have been traditionally considered as those in the 90th and 95th percentiles; low values were considered to be those below the 5th percentile. The NIH Concensus Conference has recently revised the values concerning cholesterol, however, in view of clear evidence of an increased risk of coronary atherosclerosis in persons falling in the 75th to 90th percentiles. According to this last statement, cholesterol levels below 200 mg/dl are classified as "desirable blood cholesterol," those 200 to 239 mg/dl as "borderline-high blood cholesterol," and those 240 mg/dl and above as "high blood cholesterol."
Copyright © 1990, Butterworth Publishers, a division of Reed Publishing.
Similar articles
-
Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.Atherosclerosis. 1981 Apr;39(1):111-24. doi: 10.1016/0021-9150(81)90093-9. Atherosclerosis. 1981. PMID: 6941788
-
Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma fat transport system.Klin Wochenschr. 1983 Feb 1;61(3):119-32. doi: 10.1007/BF01486366. Klin Wochenschr. 1983. PMID: 6843039
-
Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.Ann Nutr Metab. 1991;35(5):261-73. doi: 10.1159/000177656. Ann Nutr Metab. 1991. PMID: 1776822
-
Introduction to Lipids and Lipoproteins.2024 Jan 14. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2024 Jan 14. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 26247089 Free Books & Documents. Review.
-
Atherogenic lipoproteins in end-stage renal disease.Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S30-3. doi: 10.1053/ajkd.2001.27393. Am J Kidney Dis. 2001. PMID: 11576918 Review.
References
-
- Ad Hoc Committee of AHA to Design a Dietary Treatment of Hyperlipoproteinemia. Recommendations for Treatment of Hyperlipidemia in Adults. A Joint Statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation. 1984;72:1067A–90A. - PubMed
-
- Brewer HB, Zech LA, Greg , RE, Schwartz D, Schaefer EJ. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med. 1983;98:623–40. - PubMed
-
- Brown MS, Goldstein JS. How LDL receptors influence cholesterol and atherosclerosis. Sci Am. 1984;251:57–66. - PubMed
-
- Castelli WP, Cooper GR, Doyle JT, Garcia-Palmieri MR, Gordon T, Homes C, Hudley SB, Kagan A, Kuckmak M, McGee D, Vicic WJ. Distribution of triglyceride and total LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chron Dis. 1977;30:147–69. - PubMed
-
- Council on Scientific Affairs, Division of Scientific Analysis and Technology, American Medical Association. Dietary and pharmacology therapy for the lipid risk factors. JAMA. 1983;250:1873–79. - PubMed
Publication types
LinkOut - more resources
Full Text Sources